AI assistant
Sending…
Cigna Group — Director's Dealing 2022
Feb 26, 2022
29918_dirs_2022-02-25_8c19fddf-ff2d-4e5f-b128-4196fecc2f93.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cigna Corp (CI)
CIK: 0001739940
Period of Report: 2022-02-23
Reporting Person: Neville Everett (EVP, Strategy and Business Dev)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-23 | Common Stock, $.01 Par Value | A | 2423.0000 | $0.0000 | Acquired | 8221.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-23 | Employee Stock Option (Right to Buy) | $227.0200 | A | 10865.0000 | Acquired | 2032-02-23 | Common Stock, $.01 Par Value (10865.0000) | Direct |
Footnotes
F1: These restricted shares vest in three equal annual installments beginning March 1, 2023.
F2: This option vests in three equal annual installments beginning March 1, 2023.
More from Cigna Group
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4